Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Blood Specimen Collection × Clear all

Carcinoma, Non-Small-Cell Lung

NCT06068088 2023-10-05

LUNGDIET

Unknown

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Fasting

NCT05426317 2022-06-22

Onco-PDL1s/B2M

Phase NA Unknown

100 enrolled

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Unknown

130 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT04145232 2020-08-10

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04153526 2019-11-06

LUCID

Unknown

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03771404 2018-12-11

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Phase NA Unknown

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02894853 2017-09-14

LEMA

Unknown

1,297 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01003522 2009-10-28

RESTORE-AIR

Phase 3 Unknown

60 enrolled

Thoracic

Airway Obstruction, Carcinoma, Non-Small-Cell Lung

Clinical Trials

PROTEON

LUNGDIET

Onco-PDL1s/B2M

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

LUCID

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

LEMA

RESTORE-AIR